TEE
AGN

Tibra Equities Europe’s Allergan plc AGN Stock Holding History

Tibra Equities Europe’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-18,613
Closed -$3.3M – 8
2020
Q1 		$3.3M Buy
+18,613
New +$3.5M 50.5% 1
2019
Q4 		– Sell
-256,514
Closed -$43.2M – 336
2019
Q3 		$43.2M Buy
+256,514
New +$41.8M 5.33% 3
2018
Q4 		– Sell
-48,611
Closed -$9.26M – 321
2018
Q3 		$9.26M Buy
+48,611
New +$8.93M 1.09% 21

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Tibra Equities Europe's AGN Position: Q2 2020 in Review

Tibra Equities Europe sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 18,613 shares — an estimated $3.3M sold.

Tibra Equities Europe first reported a position in AGN in Q3 2018 and held it in 3 quarters. The position peaked at $43.2M in Q3 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Tibra Equities Europe reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Tibra Equities Europe sold 18,613 Allergan plc shares in Q2 2020, an estimated $3.3M.
  • Tibra Equities Europe first reported a position in Allergan plc in Q3 2018 and held it in 3 quarters.
  • Tibra Equities Europe's Allergan plc position peaked at $43.2M in Q3 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Tibra Equities Europe's 13F filing for Q2 2020, filed 14 Aug 2020.